Your browser doesn't support javascript.
loading
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition.
Mitchell, Rebecca; Hopcroft, Lisa E M; Baquero, Pablo; Allan, Elaine K; Hewit, Kay; James, Daniel; Hamilton, Graham; Mukhopadhyay, Arunima; O'Prey, Jim; Hair, Alan; Melo, Junia V; Chan, Edmond; Ryan, Kevin M; Maguer-Satta, Véronique; Druker, Brian J; Clark, Richard E; Mitra, Subir; Herzyk, Pawel; Nicolini, Franck E; Salomoni, Paolo; Shanks, Emma; Calabretta, Bruno; Holyoake, Tessa L; Helgason, G Vignir.
Afiliación
  • Mitchell R; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Hopcroft LEM; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Baquero P; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Allan EK; Scottish National Blood Transfusion Service, Gartnavel General Hospital, Glasgow, UK.
  • Hewit K; Cancer Research UK, Beatson Institute, Garscube Estate, Glasgow, UK.
  • James D; Cancer Research UK, Beatson Institute, Garscube Estate, Glasgow, UK.
  • Hamilton G; Glasgow Polyomics, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Mukhopadhyay A; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • O'Prey J; Cancer Research UK, Beatson Institute, Garscube Estate, Glasgow, UK.
  • Hair A; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Melo JV; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia and Imperial College, London, UK.
  • Chan E; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Ryan KM; Cancer Research UK, Beatson Institute, Garscube Estate, Glasgow, UK.
  • Maguer-Satta V; Hématologie Clinique 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
  • Druker BJ; Division of Hematology and Medical Oncology, Oregon Health and Science University, Knight Cancer Institute, Portland, OR.
  • Clark RE; Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK.
  • Mitra S; Department of Haematology, Milton Keynes Hospital NHS Foundation Trust, Milton Keynes, UK.
  • Herzyk P; Glasgow Polyomics, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Nicolini FE; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK.
  • Salomoni P; Hématologie Clinique 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
  • Shanks E; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, Paul O'Gorman Building, London, UK.
  • Calabretta B; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia and Imperial College, London, UK.
  • Holyoake TL; Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
  • Helgason GV; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
J Natl Cancer Inst ; 110(5): 467-478, 2018 05 01.
Article en En | MEDLINE | ID: mdl-29165716
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autofagia / Leucemia Mielógena Crónica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión bcr-abl / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Serina-Treonina Quinasas TOR Idioma: En Revista: J Natl Cancer Inst Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autofagia / Leucemia Mielógena Crónica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión bcr-abl / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Serina-Treonina Quinasas TOR Idioma: En Revista: J Natl Cancer Inst Año: 2018 Tipo del documento: Article